[Which patients with acute coronary syndrome without ST segment elevation should be handled
C Kaiser1, N Balmelli, M Pfisterer
1Abteilung für Kardiologie, Bereich Innere Medizin I, Kantonsspital Basel. ckaiser@uhbs.ch
Insights
Early angioplasty is now more effective for acute coronary syndrome without ST-elevation, thanks to safer procedures and new antithrombotic drugs. Improved risk-stratification allows personalized treatment strategies for better patient outcomes.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Trials
Background:
- Historically, acute coronary syndrome without ST-elevation was managed with medical stabilization, with revascularization reserved for persistent ischemia.
- Advancements in coronary stenting and potent antithrombotic agents have significantly improved the safety and efficacy of early angioplasty.
Purpose of the Study:
- To review randomized clinical trials comparing conservative versus invasive strategies for acute coronary syndrome without ST-elevation.
- To introduce a novel algorithm for risk-stratification and therapeutic decision-making in these patients.
Main Methods:
- Analysis of key randomized clinical trials.
- Development of a new risk-stratification and treatment algorithm.
Main Results:
- Early angioplasty, combined with advanced antithrombotic therapies, demonstrates increased effectiveness.
- Risk-stratification enables tailored therapeutic approaches based on individual patient risk status.
Conclusions:
- The paradigm for managing acute coronary syndrome without ST-elevation has shifted towards earlier invasive strategies.
- A refined risk-stratification algorithm can optimize individualized treatment plans, improving patient management.
Abstract:
Until recently the therapeutic approach in patients with acute coronary syndrome without ST-segment elevation focused on medical stabilization. Usually cardiac catheterization and revascularisation were performed later only if the stabilized patient had provoked ischemia. Since angioplasty became safer with the introduction of coronary stents, and since new potent antithrombotic agents (i.e. tienopyridines or glycoprotein-receptorIIb/IIIa-antagonists) have been developed, early angioplasty has become much more effective. Moreover major progress has been made in risk-stratification, which allow an individual therapeutic strategy for each patient according to his risk-status. We discuss the most important randomised clinical trials comparing a conservative versus an invasive strategy and introduce a new algorithm for risk-stratification und therapy in acute coronary syndromes without ST-elevation.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome V: Nursing Management
Angina II: Classification

